Company intelligence / Profile preview

CoronaCure

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

CoronaCure is a private biotech subsidiary formed by AntiCancer to develop therapies for COVID-19. Publicly available information indicates the company was established in 2020 as CoronaCure LLC and is based in San Diego, California. Its disclosed lead program is methioninase (rMETase), an enzyme-based therapeutic that was described as being developed for COVID-19 and listed in drug intelligence databases as preclinical or pending/preclinical. Available public information on the company is sparse, and there is little evidence of a broader disclosed pipeline, partnerships, financing history, or commercial operations beyond its role as an AntiCancer subsidiary.

Therapeutic areas: Infectious Diseases
Modalities: Recombinant proteaseProtein
Industry: Biotech

Beyond the preview

Go deeper on CoronaCure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CoronaCure.

Explore the full profile